netFormulary
 Report : A-Z HCD items in Formulary 19/11/2018 21:47:58
[Back]
 
Section Status BlueTeq Name
08.03.04.02 Formulary BlueTeq Abiraterone acetate Zytiga ®
11.04.02 Restricted Use BlueTeq Adalimumab Humira®
08.01.05 Formulary BlueTeq Alectinib Alecensa®
08.02.04 Formulary BlueTeq Alemtuzumab Lemtrada®
10.01.03 Restricted Use BlueTeq Anakinra Kineret®
08.01.05 Formulary BlueTeq Arsenic Trioxide Trisenox®
08.01.05 Formulary BlueTeq Atezolizumab Tecentriq®
08.01.05 Formulary BlueTeq Avelumab Bavencio®
08.01.01 Formulary BlueTeq Bendamustine Levact®
08.01.05 Formulary BlueTeq Bevacizumab Avastin®
08.02.03 Formulary BlueTeq Blinatumomab Blincyto®
08.01.05 Formulary BlueTeq Bortezomib Velcade®
08.01.05 Formulary BlueTeq Bosutinib Bosulif®
08.01.05 Formulary BlueTeq Brentuximab vedotin Adcetris®
08.01.05 Formulary BlueTeq Cabazitaxel Jevtana®
08.01.05 Formulary BlueTeq Cabozantinib Cometriq®, Cabometyx®
08.01.05 Formulary BlueTeq Carfilzomib Kyprolis®
08.01.05 Formulary BlueTeq Ceritinib Zykadia®
08.01.05 Formulary BlueTeq Cetuximab Erbitux®
08.02.04 Formulary BlueTeq Cladribine Mavenclad®
08.01.03 Formulary BlueTeq Clofarabine Evoltra®
08.01.05 Formulary BlueTeq Crizotinib Xalkori®
05.03.03.02 Formulary BlueTeq Daclatasvir Daklinza®
08.02.04 Non Formulary BlueTeq Daclizumab Zinbryta®
08.01.05 Formulary BlueTeq Daratumumab DARZALEX®
05.03.03.02 Formulary BlueTeq Dasabuvir Exviera®
08.01.05 Formulary BlueTeq Dasatinib Sprycel®
08.02.04 Formulary BlueTeq Dimethyl fumarate Tecfidera®
08.01.02 Formulary BlueTeq Doxorubicin Hydrochloride Caelyx®
09.01.03 Restricted Use BlueTeq Eculizumab Soliris®
05.03.03.02 Formulary BlueTeq Elbasvir with Grazoprevir Zepatier®
09.08.01 Restricted Use BlueTeq Eliglustat Cerdelga®
02.11 Restricted Use BlueTeq Emicizumab Hemlibra®
08.01.05 Formulary BlueTeq Eribulin Halaven®
09.05.01.02 Formulary BlueTeq Etelcalcetide Parsabiv®
08.01.05 Formulary BlueTeq Everolimus Afinitor®
08.02.04 Formulary BlueTeq Fingolimod Gilenya®
08.01.05 Formulary BlueTeq Gemtuzumab ozogamicin MYLOTARG®
08.02.04 Formulary BlueTeq Glatiramer Acetate Copaxone®
05.03.03.02 Formulary BlueTeq Glecaprevir with Pibrentasvir Maviret®
11.99.99.99 Restricted Use BlueTeq Holoclar® Viable autologous human corneal epithelial cells
08.01.05 Formulary BlueTeq Ibrutinib Imbruvica®
09.08.01 Restricted Use BlueTeq Imiglucerase Cerezyme®
08.01.05 Formulary BlueTeq Inotuzumab ozogamicin BESPONSA®
08.02.04 Formulary BlueTeq Interferon Beta-1a & Interferon Beta 1-b Avonex®, Rebif®, Extavia®
08.01.05 Formulary BlueTeq Ixazomib Ninlaro®
08.01.05 Formulary BlueTeq Lenvatinib Kisplyx®, Lenvima®
08.01.05 Formulary BlueTeq Liposomal Cytarabine-Daunorubicin Vyxeos®
08.01.05 Formulary BlueTeq Lutetium (177Lu) oxodotreotide Lutathera®
03.04.02 Restricted Use BlueTeq Mepolizumab Nucala®
08.01.05 Formulary BlueTeq Midostaurin Rydapt®
08.02.04 Formulary BlueTeq Natalizumab Tysabri®
08.01.03 Formulary BlueTeq Nelarabine Atriance®
08.01.05 Formulary BlueTeq Nilotinib Tasigna®
03.11 Formulary BlueTeq Nintedanib Ofev®
08.01.05 Formulary BlueTeq Niraparib Zejula®
08.01.05 Formulary BlueTeq Nivolumab Opdivo®
01.09.01 Restricted Use BlueTeq Obeticholic acid Ocaliva®
08.02.03 Formulary BlueTeq Obinutuzumab  Gazyvaro®
08.01.05 Formulary BlueTeq Olaratumab Lartruvo®
03.04.02 Formulary BlueTeq Omalizumab Xolair®
05.03.03.02 Formulary BlueTeq Ombitasvir with Paritaprevir and Ritonavir Viekirax®
08.01.05 Formulary BlueTeq Osimertinib Tagrisso®
08.01.05 Formulary BlueTeq Paclitaxel - Albumin Bound Formulation (Nab-paclitaxel) Abraxane®
08.01.05 Formulary BlueTeq Palbociclib IBRANCE®
05.03.05 Formulary BlueTeq Palivizumab Synagis®
08.01.05 Formulary BlueTeq Panitumumab Vectibix®
08.02.04 Formulary BlueTeq Peginterferon beta-1a Plegridy®
08.01.05 Formulary BlueTeq Pembrolizumab Keytruda®
08.01.05 Formulary BlueTeq Pertuzumab Perjeta®
03.11 Restricted Use BlueTeq Pirfenidone Esbriet®
09.01.07 Formulary BlueTeq Plerixafor Mozobil®
08.02.04 Formulary BlueTeq Pomalidomide Imnovid®
08.01.05 Formulary BlueTeq Ponatinib Iclusig®
08.01.05 Formulary BlueTeq Regorafenib Stivarga®
03.04.02 Restricted Use BlueTeq Reslizumab Cinqaero®
08.01.05 Formulary BlueTeq Ribociclib Kisqali®
05.03.03.02 Formulary BlueTeq Sofosbuvir Sovaldi®
05.03.03.02 Formulary BlueTeq Sofosbuvir with ledipasvir Harvoni®
05.03.03.02 Formulary BlueTeq Sofosbuvir with velpatasvir Epclusa®
05.03.03.02 Formulary BlueTeq Sofosbuvir with Velpatasvir and Voxilaprevir Vosevi®
08.01.05 Formulary BlueTeq Sorafenib Nexavar®
08.01.05 Formulary BlueTeq Talimogene laherparepvec Imlygic®
08.02.04 Formulary BlueTeq Teriflunomide Aubagio®
08.01.05 Formulary BlueTeq Tivozanib Fotivda®
08.01.05 Formulary BlueTeq Trametinib Mekinist®
08.01.05 Formulary BlueTeq Trastuzumab emtansine Kadcyla®
08.01.03 Formulary BlueTeq Trifluridine–tipiracil Lonsurf®
08.01.05 Formulary BlueTeq Vandetanib Caprelsa®
09.08.01 Restricted Use BlueTeq Velaglucerase alfa VPRIV®
08.01.05 Formulary BlueTeq Venetoclax Venclyxto®
Dorset